Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
niacin (1 trial)
nicotinamide (1 trial)
psilocybin (10 trials)
5-meo-dmt (1 trial)
cellulose (1 trial)
moxifloxacin (avelox) (1 trial)
Depression (Phase 2)
Depressive Disorder (Phase 2)
Depressive Disorder, Major (Phase 2)
Depressive Disorder, Treatment-Resistant (Phase 2)
Trials (11 total)
Trial APIs (6 total)